반응식
[F:1][C:2]1[CH:7]=[CH:6][C:5]([F:8])=[CH:4][C:3]=1[C:9]1[C:13]2[CH2:14][N:15]([CH3:18])[CH2:16][CH2:17][C:12]=2[N:11]([C:19]([NH:21][C@@H:22]([C:27]([CH3:30])([CH3:29])[CH3:28])[C:23](NC)=[O:24])=[O:20])[N:10]=1.N[C@H](CO)C(C)(C)C>>[F:1][C:2]1[CH:7]=[CH:6][C:5]([F:8])=[CH:4][C:3]=1[C:9]1[C:13]2[CH2:14][N:15]([CH3:18])[CH2:16][CH2:17][C:12]=2[N:11]([C:19]([NH:21][C@@H:22]([C:27]([CH3:30])([CH3:29])[CH3:28])[CH2:23][OH:24])=[O:20])[N:10]=1참가 물질
3
반응물 2
생성물 1
실험 절차
Compound 66 was prepared according to the procedure described for the synthesis of compound 64 by replacing tert-leucine methylamide with tert-leucinol. LCMS (+ESI) m/z=393.3 [M+H]+.
출처 및 근거
- ORD 기록
- ord-e36008064eeb4e7dbd22fcff7646e1d0
- 출처 데이터셋
- uspto-grants-2014_02
- 특허 번호
- US08653127B2
연결된 노트
불러오는 중…